ArticleCancer biology & therapy2018

Efficacy generated by afatinib in a lung adenocarcinoma patient harboring HER2 S310Y mutation.

Jian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.